首页 | 本学科首页   官方微博 | 高级检索  
     

胸腺肽α1对老年重症医院获得性肺炎患者免疫功能的影响
引用本文:王卫,全胜麟,李莹. 胸腺肽α1对老年重症医院获得性肺炎患者免疫功能的影响[J]. 中国医院药学杂志, 2011, 0(17)
作者姓名:王卫  全胜麟  李莹
作者单位:云南省第一人民医院昆明医学院附属昆华医院;
摘    要:目的:探讨胸腺肽α1治疗对老年重症医院获得性肺炎(SHAP)患者细胞免疫功能的影响及其临床意义。方法:48例SHAP患者随机分为治疗组和对照组。治疗组在对照组基础上给予胸腺肽α1 1.6 mg皮下注射,qd,持续1周,之后改为1.6 mg,皮下注射,隔日一次,共2周。结果:治疗组治疗后单核细胞人类白细胞抗原(HLA-DR)、自然杀伤(NK)细胞、CD4+细胞及CD4+/CD8+比值明显上升;治疗组住院死亡率明显低于对照组,其存活者抗生素应用时间亦比对照组明显缩短。结论:胸腺肽α1能提高SHAP患者免疫功能,有利于感染控制,并降低住院死亡率。

关 键 词:胸腺肽α1  老年  重症医院获得性肺炎  免疫功能  

The influence of thymosin alpha 1 on immune function of elder patients with severe hospital acquired pneumonia
WANG Wei,QUAN Sheng-lin,LI Yin. The influence of thymosin alpha 1 on immune function of elder patients with severe hospital acquired pneumonia[J]. Chinese Journal of Hospital Pharmacy, 2011, 0(17)
Authors:WANG Wei  QUAN Sheng-lin  LI Yin
Affiliation:WANG Wei,QUAN Sheng-lin,LI Yin (The First People's Hospital of Yunnan Provice,Yunnan Kunming 650032,China)
Abstract:OBJECTIVE To investigate the influence of thymosin alpha 1 on immune function and the clinical significance in elder patients with severe hospital acquired pneumonia(SHAP). METHODS A total of 48 elder patients with SHAP were randomly divided into 2 groups: the treatment group(n=24) and the control group(n=24).The treatment group received 1.6 mg of thymosin alpha1 through subcutaneous injection qd for a week,then received 1.6 mg of thymosin alpha1 through subcutaneous injection every other day for two weeks;...
Keywords:thymosin alpha 1  elder  severe hospital acquired pneumonia  immune function  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号